Co-administered gastrointestinal drugs and toxins

Co-administered gastrointestinal drugs and toxins is a descriptive pharmacological category rather than a specific biological macromolecule. It encompasses a wide array of exogenous substances, including pharmaceutical agents, environmental toxins, and chemical poisons, that are present within the gastrointestinal lumen (DrugBank, DB09278). These substances serve as the functional targets for gastrointestinal decontaminants such as activated charcoal, which works by physically adsorbing these molecules to its high-surface-area structure via Van der Waals forces (StatPearls, NBK482294). By sequestering these 'targets' in the gut, the decontaminant prevents their absorption into the systemic circulation, which is a critical intervention in the management of acute poisoning and drug overdoses (PubChem, CID 161241). Because this category represents a heterogeneous group of molecules rather than a single protein or receptor, it is considered an unconventional target designation in drug discovery (NIH, 2023). Interactions with this group can also lead to significant drug-drug interactions, as the non-specific binding can reduce the bioavailability of essential therapeutic medications co-administered with adsorbents.

Other names

Gastrointestinal adsorbatesCo-ingested toxinsIntraluminal drugsGastrointestinal toxins

Physical adsorption or chemical binding within the gastrointestinal lumen to prevent systemic absorption.